首页 > 最新文献

Indian Journal of Surgical Oncology最新文献

英文 中文
Immunohistochemical Expression of Interleukin-6 and Transforming Growth Factor Beta-1 on Prostatic Lesions. 白细胞介素-6和转化生长因子-1在前列腺病变中的免疫组织化学表达。
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-03-13 DOI: 10.1007/s13193-025-02276-x
Alaa Abdulqader Abdulrazaq, Duraid Taha Abdulkareem

Benign prostatic hyperplasia (BPH) and prostatic cancer both represent prostate lesions affecting males. These conditions occur due to the presence of inflammation within the prostate gland. This inflammatory process causes tissue injury and cellular modifications, which are primarily through the cytokine synthesis and secretion. Distinctly, IL-6 (interleukin 6) emerges as a vital part in prostate disease, exerting a profound influence on its development. In addition, the anti-inflammatory cytokines' inclusion, such as tumor necrosis factor beta-1 (TGFβ-1), is evident in the development of both benign prostatic hyperplasia and prostatic cancer. In recent discoveries, researchers are more focused on complex interaction between IL-6 and TGFβ-1 in the prostate pathophysiology. The article aims to assess the IL-6 and TGFβ-1 immunohistochemical expression in prostatic benign and malignant lesions. Formalin-fixed samples that were encapsulated in paraffin were utilized in this work. They were collected from the department of histopathology et al.-Ramadi-Teaching Hospital from patients who were diagnosed with hyperplasia and carcinoma of the prostate. To detect the expression of TGFβ-1 and IL-6, immunohistochemical analysis was performed on the tissue sections. The intensity of stromal staining was determined to assess the stromal expression. Concerning prostate cancer, the relationship between cytokine expression and the Gleason index score was discussed in this work. The results confirm that the TGFβ-1 was presented in the epithelial and stromal components of prostate tissue with a higher concentration in the stroma. The TGFβ-1 stromal expression was increased in cases of benign hyperplastic changes in comparison to prostate carcinoma (p < 0.05). On the contrary, the epithelial expression of TGFβ-1 did not show any significant differences between the two cases. On the other hand, IL-6 expression was localized in the epithelial component, with higher levels observed in prostate cancer in comparison to hyperplasia. There was no substantial correlation found between the Gleason score and IL-6 expression. According to our results, the immunohistochemical detection of both TGFβ-1 and IL-6 exhibited variations between benign and malignant samples.

良性前列腺增生(BPH)和前列腺癌都是影响男性的前列腺病变。这些情况的发生是由于前列腺内存在炎症。这种炎症过程主要通过细胞因子的合成和分泌引起组织损伤和细胞修饰。显然,IL-6(白细胞介素6)在前列腺疾病中起着至关重要的作用,对前列腺疾病的发展有着深远的影响。此外,肿瘤坏死因子β-1 (tgf - β-1)等抗炎细胞因子的包涵在良性前列腺增生和前列腺癌的发展中都是明显的。在最近的发现中,研究人员更关注IL-6与tgf - β-1在前列腺病理生理中的复杂相互作用。本文旨在探讨IL-6和tgf - β-1在前列腺良恶性病变中的免疫组化表达。本研究采用石蜡包封的福尔马林固定样品。它们来自拉马迪教学医院组织病理学等部门,来自诊断为前列腺增生和前列腺癌的患者。采用免疫组化方法检测tgf - β-1和IL-6的表达。测定间质染色强度,评估间质表达。针对前列腺癌,本文探讨了细胞因子表达与Gleason指数评分的关系。结果证实tgf - β-1存在于前列腺组织的上皮和间质成分中,且间质中浓度较高。与前列腺癌相比,良性增生性病变中tgf - β-1间质表达升高(p
{"title":"Immunohistochemical Expression of Interleukin-6 and Transforming Growth Factor Beta-1 on Prostatic Lesions.","authors":"Alaa Abdulqader Abdulrazaq, Duraid Taha Abdulkareem","doi":"10.1007/s13193-025-02276-x","DOIUrl":"https://doi.org/10.1007/s13193-025-02276-x","url":null,"abstract":"<p><p>Benign prostatic hyperplasia (BPH) and prostatic cancer both represent prostate lesions affecting males. These conditions occur due to the presence of inflammation within the prostate gland. This inflammatory process causes tissue injury and cellular modifications, which are primarily through the cytokine synthesis and secretion. Distinctly, IL-6 (interleukin 6) emerges as a vital part in prostate disease, exerting a profound influence on its development. In addition, the anti-inflammatory cytokines' inclusion, such as tumor necrosis factor beta-1 (TGFβ-1), is evident in the development of both benign prostatic hyperplasia and prostatic cancer. In recent discoveries, researchers are more focused on complex interaction between IL-6 and TGFβ-1 in the prostate pathophysiology. The article aims to assess the IL-6 and TGFβ-1 immunohistochemical expression in prostatic benign and malignant lesions. Formalin-fixed samples that were encapsulated in paraffin were utilized in this work. They were collected from the department of histopathology et al.-Ramadi-Teaching Hospital from patients who were diagnosed with hyperplasia and carcinoma of the prostate. To detect the expression of TGFβ-1 and IL-6, immunohistochemical analysis was performed on the tissue sections. The intensity of stromal staining was determined to assess the stromal expression. Concerning prostate cancer, the relationship between cytokine expression and the Gleason index score was discussed in this work. The results confirm that the TGFβ-1 was presented in the epithelial and stromal components of prostate tissue with a higher concentration in the stroma. The TGFβ-1 stromal expression was increased in cases of benign hyperplastic changes in comparison to prostate carcinoma (<i>p</i> < 0.05). On the contrary, the epithelial expression of TGFβ-1 did not show any significant differences between the two cases. On the other hand, IL-6 expression was localized in the epithelial component, with higher levels observed in prostate cancer in comparison to hyperplasia. There was no substantial correlation found between the Gleason score and IL-6 expression. According to our results, the immunohistochemical detection of both TGFβ-1 and IL-6 exhibited variations between benign and malignant samples.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1632-1638"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of Bayesian Network Model for Prediction of Binary Outcome: An Exploratory Study of Mortality Prediction Amongst Squamous Cell Carcinomas of Oral Cavity. 贝叶斯网络模型在二元预后预测中的应用:口腔鳞状细胞癌死亡率预测的探索性研究。
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-03-24 DOI: 10.1007/s13193-024-02164-w
Sachit Ganapathy, N Sreekumaran Nair, Harichandrakumar Kt, Prasanth Penumadu, Kadhiravan Tamilarasu

Bayesian network (BN) models are graphical structures called the directed acyclic graphs, which model the probabilistic dependencies between variables. In the context of predictive modeling, BN models can intuitively represent the collective contribution of factors in predicting an outcome variable. This study is aimed at developing a BN model in predicting the two-year mortality of patients diagnosed with squamous cell carcinoma of oral cavity (OCSCC). The secondary data for the study was obtained from a published cohort study conducted within the institute after ethical approval. The strength of association of the potential prognostic factors with the outcome variable was determined using multiple logistic regression. The hybrid BN model based on expert opinion and association matrix (BN-H) was developed. The conditional dependencies between the variables were incorporated as the thickness of edges between nodes. Multiple logistic regression (MLR) and BN models based on tree augmented (TAN), expectation maximization (EM), and gradient boosting (GB) method was developed for comparison. Gini coefficient, sensitivity, specificity, misclassification rate, and area under the ROC curve were estimated in both training and testing data for comparison. Age, smoking, alcohol, stage of the cancer, and treatment modality were found be significant prognostic factors for mortality. The association matrix determined that there were significant inter-dependencies between variables. The BN-H model was found to have a comparable predictive accuracy to the MLR model. Bayesian network model developed with expert opinion and appropriate association matrix can be an alternative to existing predictive models for binary outcome.

Supplementary information: The online version contains supplementary material available at 10.1007/s13193-024-02164-w.

贝叶斯网络(BN)模型是一种称为有向无环图的图形结构,它对变量之间的概率依赖关系进行建模。在预测建模的背景下,BN模型可以直观地表示预测结果变量的因素的集体贡献。本研究旨在建立预测口腔鳞状细胞癌(OCSCC)患者两年死亡率的BN模型。该研究的次要数据来自一项已发表的队列研究,该研究在获得伦理批准后在该研究所进行。使用多元逻辑回归确定潜在预后因素与结果变量的关联强度。建立了基于专家意见和关联矩阵的混合网络模型(BN- h)。变量之间的条件依赖关系作为节点间边的厚度。建立了基于树增强(TAN)、期望最大化(EM)和梯度增强(GB)方法的多元逻辑回归(MLR)和BN模型进行比较。对训练数据和检验数据进行基尼系数、敏感性、特异性、误分类率和ROC曲线下面积的估计,进行比较。年龄、吸烟、饮酒、癌症分期和治疗方式是死亡率的重要预后因素。关联矩阵确定变量之间存在显著的相互依赖关系。BN-H模型被发现具有与MLR模型相当的预测精度。利用专家意见和适当的关联矩阵建立贝叶斯网络模型可以替代现有的二元结果预测模型。补充信息:在线版本包含补充资料,提供地址为10.1007/s13193-024-02164-w。
{"title":"Utility of Bayesian Network Model for Prediction of Binary Outcome: An Exploratory Study of Mortality Prediction Amongst Squamous Cell Carcinomas of Oral Cavity.","authors":"Sachit Ganapathy, N Sreekumaran Nair, Harichandrakumar Kt, Prasanth Penumadu, Kadhiravan Tamilarasu","doi":"10.1007/s13193-024-02164-w","DOIUrl":"https://doi.org/10.1007/s13193-024-02164-w","url":null,"abstract":"<p><p>Bayesian network (BN) models are graphical structures called the directed acyclic graphs, which model the probabilistic dependencies between variables. In the context of predictive modeling, BN models can intuitively represent the collective contribution of factors in predicting an outcome variable. This study is aimed at developing a BN model in predicting the two-year mortality of patients diagnosed with squamous cell carcinoma of oral cavity (OCSCC). The secondary data for the study was obtained from a published cohort study conducted within the institute after ethical approval. The strength of association of the potential prognostic factors with the outcome variable was determined using multiple logistic regression. The hybrid BN model based on expert opinion and association matrix (BN-H) was developed. The conditional dependencies between the variables were incorporated as the thickness of edges between nodes. Multiple logistic regression (MLR) and BN models based on tree augmented (TAN), expectation maximization (EM), and gradient boosting (GB) method was developed for comparison. Gini coefficient, sensitivity, specificity, misclassification rate, and area under the ROC curve were estimated in both training and testing data for comparison. Age, smoking, alcohol, stage of the cancer, and treatment modality were found be significant prognostic factors for mortality. The association matrix determined that there were significant inter-dependencies between variables. The BN-H model was found to have a comparable predictive accuracy to the MLR model. Bayesian network model developed with expert opinion and appropriate association matrix can be an alternative to existing predictive models for binary outcome.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13193-024-02164-w.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1696-1704"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Additional Risk Factors Lead to a Measurable Inflammatory Response in Stage I Endometrial Cancer-A Prospective Multicentric Observational Study. 额外的危险因素导致I期子宫内膜癌可测量的炎症反应——一项前瞻性多中心观察研究
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-02-24 DOI: 10.1007/s13193-025-02228-5
Carlo Ronsini, Irene Iavarone, Maria Giovanna Vastarella, Luigi Della Corte, Giada Andreoli, Giuseppe Bifulco, Luigi Cobellis, Pasquale de Franciscis

The objective of the study is to explore the correlation between inflammation indices (NLR, MLR, PLR) and prognostic factors (myometrial infiltration, LVSI, grading) in FIGO 2023 stage I endometrial carcinoma. From August 2023 to March 2024, a prospective study was conducted on 163 women diagnosed with stage I endometrial cancer. The research methods were established a priori and authorized through evaluation by the Ethics Committee of the individual centers (IRB 30661/2022 of 31/03/2022). The study was then registered on the clinicaltrials.gov platform under NCT05657483. Blood samples were collected preoperatively to measure the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR). Histopathological data on myometrial infiltration, LVSI, and grading were also analyzed. NLR values were 2.07, 2.35, and 2.68 for no infiltration, < 50%, and ≥ 50% myometrial infiltration, respectively (p = 0.033). MLR values were 0.20, 0.23, and 0.26 for the same categories (p = 0.029). PLR values were 119, 140, and 146 (p = 0.043). For LVSI, NLR was 2.17 in negative and 3.23 in diffuse (p = 0.010), while MLR showed 0.20 vs 0.24 (p = 0.054), and PLR showed 125 vs 141 (p = 0.033). Multivariate analysis indicated myometrial infiltration had the strongest correlation with inflammation indices (beta 0.07, CI 95% 0.01-0.13, p = 0.041). Inflammation indices (NLR, MLR, PLR) significantly correlate with myometrial infiltration, LVSI positivity, and higher grading in early-stage endometrial carcinoma, with myometrial infiltration showing the strongest association. These findings suggest that inflammation indices could aid in the prognostic evaluation of endometrial carcinoma. Further research is needed to understand the prognostic implications fully.

本研究旨在探讨FIGO 2023期I期子宫内膜癌炎症指标(NLR、MLR、PLR)与预后因素(肌层浸润、LVSI、分级)的相关性。从2023年8月到2024年3月,对163名诊断为I期子宫内膜癌的女性进行了一项前瞻性研究。研究方法是先验建立的,并通过各中心伦理委员会的评估授权(IRB 30661/2022年3月31日)。该研究随后在clinicaltrials.gov平台注册,编号为NCT05657483。术前采集血液,测定中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)、血小板与淋巴细胞比值(PLR)。我们还分析了肌层浸润、LVSI和分级的组织病理学数据。无浸润的NLR分别为2.07、2.35、2.68,p = 0.033)。同一类别的MLR值分别为0.20、0.23和0.26 (p = 0.029)。PLR值分别为119、140和146 (p = 0.043)。LVSI阴性NLR为2.17,弥漫NLR为3.23 (p = 0.010), MLR为0.20 vs 0.24 (p = 0.054), PLR为125 vs 141 (p = 0.033)。多因素分析显示,肌层浸润与炎症指标相关性最强(β - 0.07, CI 95% 0.01 ~ 0.13, p = 0.041)。早期子宫内膜癌炎症指标(NLR、MLR、PLR)与子宫内膜浸润、LVSI阳性、分级高相关,其中以子宫内膜浸润相关性最强。这些结果提示炎症指标可以帮助评价子宫内膜癌的预后。需要进一步的研究来充分了解其预后意义。
{"title":"Additional Risk Factors Lead to a Measurable Inflammatory Response in Stage I Endometrial Cancer-A Prospective Multicentric Observational Study.","authors":"Carlo Ronsini, Irene Iavarone, Maria Giovanna Vastarella, Luigi Della Corte, Giada Andreoli, Giuseppe Bifulco, Luigi Cobellis, Pasquale de Franciscis","doi":"10.1007/s13193-025-02228-5","DOIUrl":"10.1007/s13193-025-02228-5","url":null,"abstract":"<p><p>The objective of the study is to explore the correlation between inflammation indices (NLR, MLR, PLR) and prognostic factors (myometrial infiltration, LVSI, grading) in FIGO 2023 stage I endometrial carcinoma. From August 2023 to March 2024, a prospective study was conducted on 163 women diagnosed with stage I endometrial cancer. The research methods were established a priori and authorized through evaluation by the Ethics Committee of the individual centers (IRB 30661/2022 of 31/03/2022). The study was then registered on the clinicaltrials.gov platform under NCT05657483. Blood samples were collected preoperatively to measure the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR). Histopathological data on myometrial infiltration, LVSI, and grading were also analyzed. NLR values were 2.07, 2.35, and 2.68 for no infiltration, < 50%, and ≥ 50% myometrial infiltration, respectively (<i>p</i> = 0.033). MLR values were 0.20, 0.23, and 0.26 for the same categories (<i>p</i> = 0.029). PLR values were 119, 140, and 146 (<i>p</i> = 0.043). For LVSI, NLR was 2.17 in negative and 3.23 in diffuse (<i>p</i> = 0.010), while MLR showed 0.20 vs 0.24 (<i>p</i> = 0.054), and PLR showed 125 vs 141 (<i>p</i> = 0.033). Multivariate analysis indicated myometrial infiltration had the strongest correlation with inflammation indices (beta 0.07, CI 95% 0.01-0.13, <i>p</i> = 0.041). Inflammation indices (NLR, MLR, PLR) significantly correlate with myometrial infiltration, LVSI positivity, and higher grading in early-stage endometrial carcinoma, with myometrial infiltration showing the strongest association. These findings suggest that inflammation indices could aid in the prognostic evaluation of endometrial carcinoma. Further research is needed to understand the prognostic implications fully.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1474-1481"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adenoid Cystic Carcinoma of Breast-A Narrative Review. 乳腺腺样囊性癌述评
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-04-02 DOI: 10.1007/s13193-025-02281-0
Subbiah Shanmugam, Archana Elangovan, Bricilla Gnana Preethe, Partheeban Balasundaram, Archana Elangovan

Adenoid cystic carcinoma, predominantly a tumour of salivary gland, very rarely affects the breast. Very few cases have been reported in literature and there is no optimal consensus on management. In this narrative review, we report a case of adenoid cystic carcinoma breast treated with surgery followed by adjuvant chemotherapy and radiation therapy. It is an indolent tumour with very low predilection for lymphatic dissemination. A balanced translocation in MYB-NFIB fusion gene appears to be fundamental in the pathogenesis. Surgery forms the mainstay treatment option followed by adjuvant radiation in high risk cases, as extrapolated from studies in salivary gland tumour.

腺样囊性癌,主要是一种涎腺肿瘤,很少影响乳房。文献报道的病例很少,对管理也没有最佳共识。在这篇叙述性的回顾中,我们报告一例腺样囊性乳腺癌的手术治疗后,辅助化疗和放疗。它是一种惰性肿瘤,很少倾向于淋巴传播。MYB-NFIB融合基因的平衡易位似乎是其发病机制的基础。根据唾液腺肿瘤的研究推断,手术是高危病例的主要治疗选择,其次是辅助放疗。
{"title":"Adenoid Cystic Carcinoma of Breast-A Narrative Review.","authors":"Subbiah Shanmugam, Archana Elangovan, Bricilla Gnana Preethe, Partheeban Balasundaram, Archana Elangovan","doi":"10.1007/s13193-025-02281-0","DOIUrl":"https://doi.org/10.1007/s13193-025-02281-0","url":null,"abstract":"<p><p>Adenoid cystic carcinoma, predominantly a tumour of salivary gland, very rarely affects the breast. Very few cases have been reported in literature and there is no optimal consensus on management. In this narrative review, we report a case of adenoid cystic carcinoma breast treated with surgery followed by adjuvant chemotherapy and radiation therapy. It is an indolent tumour with very low predilection for lymphatic dissemination. A balanced translocation in MYB-NFIB fusion gene appears to be fundamental in the pathogenesis. Surgery forms the mainstay treatment option followed by adjuvant radiation in high risk cases, as extrapolated from studies in salivary gland tumour.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1745-1747"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Cholecystectomy and Colorectal Cancer. 胆囊切除术与结直肠癌的关系
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-02-25 DOI: 10.1007/s13193-025-02255-2
Adithya Sathya Narayana, Sreekar Agumbe Pai, Advaith N Rao, Anisha Dhavaleshwar

Aim: To find the association between cholecystectomy and colorectal cancer.

Methodology: This is a case control study which consisted of 138 cases and 140 controls. This study was conducted with the ethical approval of the ethics committee and has also received the ICMR STS grant. Data of 138 patients who were diagnosed with colorectal cancer in the last 5 years were analyzed for a history of cholecystectomy. Those who developed colorectal cancer within a year of their cholecystectomy were excluded from the study to minimize protopathic bias. The control group was composed of healthy individuals. Data extracted was organized in Microsoft Excel and was analyzed about the main objective. Chi-square test was used to find the association between cholecystectomy and colorectal cancer.

Results: The percentage of cholecystectomy in the colorectal cancer group was 6.5% vs 2.1% in the control group (P value = 0.072). There were no statistically significant associations between diabetes, hypertension, CKD, alcohol intake or smoking, and the incidence of colorectal cancer.

Conclusion: Based on our study, there is no evidence to support an association between colorectal cancer and cholecystectomy.

目的:探讨胆囊切除术与结直肠癌的关系。方法:这是一项病例对照研究,包括138例病例和140例对照。这项研究得到了伦理委员会的伦理批准,并获得了ICMR STS的资助。本研究分析了近5年确诊为结直肠癌的138例患者的胆囊切除术史。那些在胆囊切除术后一年内患结直肠癌的患者被排除在研究之外,以尽量减少原发病变的偏倚。对照组由健康个体组成。在Microsoft Excel中整理提取的数据,并对主要目的进行分析。采用卡方检验发现胆囊切除术与结直肠癌之间的关系。结果:结直肠癌组胆囊切除术比例为6.5%,对照组为2.1% (P值= 0.072)。糖尿病、高血压、慢性肾病、饮酒或吸烟与结直肠癌发病率之间无统计学意义的关联。结论:根据我们的研究,没有证据支持结直肠癌和胆囊切除术之间的联系。
{"title":"Association Between Cholecystectomy and Colorectal Cancer.","authors":"Adithya Sathya Narayana, Sreekar Agumbe Pai, Advaith N Rao, Anisha Dhavaleshwar","doi":"10.1007/s13193-025-02255-2","DOIUrl":"https://doi.org/10.1007/s13193-025-02255-2","url":null,"abstract":"<p><strong>Aim: </strong>To find the association between cholecystectomy and colorectal cancer.</p><p><strong>Methodology: </strong>This is a case control study which consisted of 138 cases and 140 controls. This study was conducted with the ethical approval of the ethics committee and has also received the ICMR STS grant. Data of 138 patients who were diagnosed with colorectal cancer in the last 5 years were analyzed for a history of cholecystectomy. Those who developed colorectal cancer within a year of their cholecystectomy were excluded from the study to minimize protopathic bias. The control group was composed of healthy individuals. Data extracted was organized in Microsoft Excel and was analyzed about the main objective. Chi-square test was used to find the association between cholecystectomy and colorectal cancer.</p><p><strong>Results: </strong>The percentage of cholecystectomy in the colorectal cancer group was 6.5% vs 2.1% in the control group (<i>P</i> value = 0.072). There were no statistically significant associations between diabetes, hypertension, CKD, alcohol intake or smoking, and the incidence of colorectal cancer.</p><p><strong>Conclusion: </strong>Based on our study, there is no evidence to support an association between colorectal cancer and cholecystectomy.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1504-1507"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Analysis of Clinical Presentation, Radiological Features, Management, and Oncological Outcome of Endometrial Stromal Sarcoma: A Retrospective Study. 更正:子宫内膜间质肉瘤的临床表现、影像学特征、治疗和肿瘤预后分析:一项回顾性研究。
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-04-04 DOI: 10.1007/s13193-025-02277-w
Kanagavarshani Murali, Mohana Devi, Bhawana A Badhe, Arpitha Anantharaju

[This corrects the article DOI: 10.1007/s13193-025-02188-w.].

[这更正了文章DOI: 10.1007/s13193-025-02188-w.]。
{"title":"Correction: Analysis of Clinical Presentation, Radiological Features, Management, and Oncological Outcome of Endometrial Stromal Sarcoma: A Retrospective Study.","authors":"Kanagavarshani Murali, Mohana Devi, Bhawana A Badhe, Arpitha Anantharaju","doi":"10.1007/s13193-025-02277-w","DOIUrl":"https://doi.org/10.1007/s13193-025-02277-w","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1007/s13193-025-02188-w.].</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1769"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of Gleason Score Prostate - A Review. 前列腺Gleason评分的发展综述。
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-02-27 DOI: 10.1007/s13193-025-02251-6
Cherry Bansal, Gurupriya Anand, Anshika Goyal

Gleason grading system was first introduced in the 1960s by Dr. Donald Gleason and has since been used worldwide for the grading of prostate cancer. Over the years it has undergone several modifications but has still retained its status as the most popular scoring system for prostate. Using a systematic literature review, we aim to highlight the changes the Gleason scoring has undergone, their strengths and limitations as well the future directives. Gleason scoring underwent major changes from its original conception in the International Society of Urologic Pathology (ISUP) consensus meetings held in 2005, 2014 and 2019. The latest change in Gleason scoring makes it possible to report the scoring, help alleviate patient anxiety and has shown good reproducibility and less inter-user variability. Gleason scoring system is a popular tool among pathologists and clinicians alike owing to its flexibility, utility and dependability. With advancements in the medical field and the use of artificial intelligence, it is expected to undergo further tempering.

Gleason分级系统于20世纪60年代由Donald Gleason博士首次引入,此后在全球范围内用于前列腺癌的分级。多年来,它经历了几次修改,但仍然保持其作为最流行的前列腺评分系统的地位。通过系统的文献回顾,我们的目标是强调格里森评分所经历的变化,它们的优势和局限性以及未来的指示。在2005年、2014年和2019年举行的国际泌尿病理学会(ISUP)共识会议上,格里森评分从最初的概念经历了重大变化。Gleason评分的最新变化使报告评分成为可能,有助于减轻患者的焦虑,并显示出良好的可重复性和较少的用户间差异。格里森评分系统由于其灵活性、实用性和可靠性,在病理学家和临床医生中都是一种流行的工具。随着医疗领域的进步和人工智能的使用,预计它将经历进一步的磨练。
{"title":"Evolution of Gleason Score Prostate - A Review.","authors":"Cherry Bansal, Gurupriya Anand, Anshika Goyal","doi":"10.1007/s13193-025-02251-6","DOIUrl":"https://doi.org/10.1007/s13193-025-02251-6","url":null,"abstract":"<p><p>Gleason grading system was first introduced in the 1960s by Dr. Donald Gleason and has since been used worldwide for the grading of prostate cancer. Over the years it has undergone several modifications but has still retained its status as the most popular scoring system for prostate. Using a systematic literature review, we aim to highlight the changes the Gleason scoring has undergone, their strengths and limitations as well the future directives. Gleason scoring underwent major changes from its original conception in the International Society of Urologic Pathology (ISUP) consensus meetings held in 2005, 2014 and 2019. The latest change in Gleason scoring makes it possible to report the scoring, help alleviate patient anxiety and has shown good reproducibility and less inter-user variability. Gleason scoring system is a popular tool among pathologists and clinicians alike owing to its flexibility, utility and dependability. With advancements in the medical field and the use of artificial intelligence, it is expected to undergo further tempering.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1538-1545"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Study of Survival Outcomes in Well-Differentiated Thyroid Carcinomas at a Tertiary Health Center in South India. 印度南部三级医疗中心高分化甲状腺癌患者生存结局的研究
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-03-04 DOI: 10.1007/s13193-025-02266-z
Elizabeth M Iype, Shirish Patil, Japneet Kaur, Sreekumar A, Preethi S George, Nebu Abraham George, Bipin Thomas Varghese, Shaji Thomas

Papillary thyroid carcinoma and follicular thyroid carcinoma both are collectively referred as well-differentiated thyroid carcinomas (WDTC). Both carcinoma types carry an excellent prognosis except in cases with aggressive backgrounds or clinicopathological features. We herein investigated survival rates and various prognostic factors in patients with WDTC. In this retrospective study, a total of 602 patients diagnosed as having WDTC, who had undergone total thyroidectomy with or without neck dissection and had received adequate radioactive iodine treatment from January, 2006, to December, 2008 were included. Data were collected by medical record review. Size of the tumor (p < 0.001) and extrathyroidal extension (p < 0.001) were factors for developing regional lymph node metastasis. Nodal metastasis N0 (central compartment) and N1 (lateral compartment) did not adversely affect 7-year overall survival (p < 0.8). For both regional metastasis (p = 0.001) and distant metastasis (p = 0.025), age > 55 years adversely affected overall survival. No significant difference was found in 7-year overall survival between patients with gross and microscopic extrathyroidal extension (77.6% vs. 74.5%, p = 0.18), 10-year overall survival with gross and microscopic extrathyroidal extension was also non-significant (71.1% vs. 81.3%, p = 0.509). There was no role of prophylactic central compartment neck dissection in treating patients with WDTC. Overall survival at 3, 5, 7 years, and 10 years were 94.2%, 88.8%, 85.2%, and 82.7%, respectively. It can be concluded that the survival was adversely influenced by advanced age (> 55 years). Moreover, poor long-term overall survival and disease-free survival were observed in our study population owing to advanced stage carcinoma (extrathyroidal extension and lymph node metastasis) at presentation.

甲状腺乳头状癌和甲状腺滤泡癌统称为高分化甲状腺癌(WDTC)。除了具有侵袭性背景或临床病理特征的病例外,两种类型的肿瘤预后都很好。我们在此研究了WDTC患者的生存率和各种预后因素。本回顾性研究纳入了2006年1月至2008年12月602例诊断为WDTC的患者,这些患者均行甲状腺全切除术伴或不伴颈部清扫,并接受了足够的放射性碘治疗。数据通过病历审查收集。肿瘤大小(p = 0.001)、远处转移(p = 0.025)、年龄(0 ~ 55岁)对总生存率有不利影响。大体和镜下甲状腺外展患者的7年总生存率无显著差异(77.6%比74.5%,p = 0.18),大体和镜下甲状腺外展患者的10年总生存率也无显著差异(71.1%比81.3%,p = 0.509)。预防性中央室颈清扫术在治疗WDTC患者中没有作用。3年、5年、7年和10年的总生存率分别为94.2%、88.8%、85.2%和82.7%。由此可见,高龄(50 ~ 55岁)对生存率有不利影响。此外,在我们的研究人群中,由于出现晚期癌(甲状腺外扩张和淋巴结转移),长期总生存率和无病生存率较差。
{"title":"A Study of Survival Outcomes in Well-Differentiated Thyroid Carcinomas at a Tertiary Health Center in South India.","authors":"Elizabeth M Iype, Shirish Patil, Japneet Kaur, Sreekumar A, Preethi S George, Nebu Abraham George, Bipin Thomas Varghese, Shaji Thomas","doi":"10.1007/s13193-025-02266-z","DOIUrl":"https://doi.org/10.1007/s13193-025-02266-z","url":null,"abstract":"<p><p>Papillary thyroid carcinoma and follicular thyroid carcinoma both are collectively referred as well-differentiated thyroid carcinomas (WDTC). Both carcinoma types carry an excellent prognosis except in cases with aggressive backgrounds or clinicopathological features. We herein investigated survival rates and various prognostic factors in patients with WDTC. In this retrospective study, a total of 602 patients diagnosed as having WDTC, who had undergone total thyroidectomy with or without neck dissection and had received adequate radioactive iodine treatment from January, 2006, to December, 2008 were included. Data were collected by medical record review. Size of the tumor (<i>p</i> < 0.001) and extrathyroidal extension (<i>p</i> < 0.001) were factors for developing regional lymph node metastasis. Nodal metastasis N0 (central compartment) and N1 (lateral compartment) did not adversely affect 7-year overall survival (<i>p</i> < 0.8). For both regional metastasis (<i>p</i> = 0.001) and distant metastasis (<i>p</i> = 0.025), age > 55 years adversely affected overall survival. No significant difference was found in 7-year overall survival between patients with gross and microscopic extrathyroidal extension (77.6% vs. 74.5%, <i>p</i> = 0.18), 10-year overall survival with gross and microscopic extrathyroidal extension was also non-significant (71.1% vs. 81.3%, <i>p</i> = 0.509). There was no role of prophylactic central compartment neck dissection in treating patients with WDTC. Overall survival at 3, 5, 7 years, and 10 years were 94.2%, 88.8%, 85.2%, and 82.7%, respectively. It can be concluded that the survival was adversely influenced by advanced age (> 55 years). Moreover, poor long-term overall survival and disease-free survival were observed in our study population owing to advanced stage carcinoma (extrathyroidal extension and lymph node metastasis) at presentation.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1574-1581"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and Outcomes of Salvage Therapy for Recurrence in Colorectal Cancer Patients Followed Up with a Low-Intensity Regime. 低强度治疗对结直肠癌患者复发的可行性及疗效观察。
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-02-17 DOI: 10.1007/s13193-025-02227-6
Prasanth Poolakkil, Nizamuddeen Pareekkutty, Satheesan Balasubramanian, Bindu Anilkumar

Treatment for colorectal cancer has improved significantly over the last few decades. The feasibility of treating colorectal cancer recurrence is also increasing. The surveillance protocol applied influences the pattern of diagnosis of recurrence. Adherence to intense follow up protocols may be challenged by limitation of resource, pointing to the scope of forming tailored strategies. The objectives were to determine the rate of salvage, disease-free and overall survival, the types of local therapy applied, morbidity associated with radical local treatment, and the factors influencing survival of patients followed up using a low intensity regimen after curative treatment for recurrent colorectal cancer. We included patients diagnosed with colorectal cancer recurrence from January 2010 to December 2016 at the institute. The clinicopathological and treatment details were collected. Treatment outcomes were analyzed and compared with the baseline characteristics. Of 109 recurrences, 26 (23.8%) were offered curative therapy. Locoregional treatment modalities consisted of four cases of pelvic exenteration (18.2%), four (18.2%) resections of peritoneal deposits including two (9.1%) multivisceral resections, four (18.2%) hepatic resections, two (9.1%) lung metastasectomies, one (4.5%) retroperitoneal lymph node dissection, and two (4.5%) ablative procedures. Four (18.2%) and one (4.5%) cases received chemoradiotherapy and systemic therapy alone. Surgical resection had 6.2% Clavien-Dindo grade III, 25% grade II, and 25% grade I morbidities. With a median follow-up of 95 months, the median DFS and OS were 48 months and 55 months for curatively treated patients. The rate of curative therapy was low in a low-intensity follow-up regimen (23.8%). Yet, curative treatment including complex resections offers a survival advantage with acceptable morbidity rates, in select patients with limited disease affecting a single region.

在过去的几十年里,结直肠癌的治疗有了显著的改善。治疗结直肠癌复发的可行性也在不断提高。所采用的监测方案影响复发的诊断模式。坚持严格的随访协议可能受到资源限制的挑战,指出形成量身定制的战略的范围。目的是确定恢复率,无病生存率和总生存率,局部治疗的类型,与根治性局部治疗相关的发病率,以及影响复发性结直肠癌患者在根治性治疗后使用低强度方案随访的生存率的因素。我们纳入了2010年1月至2016年12月在该研究所诊断为结直肠癌复发的患者。收集临床病理及治疗资料。分析治疗结果并与基线特征进行比较。109例复发患者中,26例(23.8%)得到有效治疗。局部治疗方式包括4例盆腔切除术(18.2%),4例腹膜沉积物切除术(18.2%),包括2例(9.1%)多脏器切除术,4例(18.2%)肝脏切除术,2例(9.1%)肺转移灶切除术,1例(4.5%)腹膜后淋巴结清扫术和2例(4.5%)消融手术。4例(18.2%)和1例(4.5%)分别接受放化疗和全身治疗。手术切除有6.2%的Clavien-Dindo III级,25%的II级和25%的I级发病率。中位随访95个月,治愈患者的中位DFS和OS分别为48个月和55个月。在低强度随访方案中治愈率低(23.8%)。然而,包括复杂切除在内的根治性治疗,在影响单一区域的有限疾病的特定患者中,提供了生存率可接受的优势。
{"title":"Feasibility and Outcomes of Salvage Therapy for Recurrence in Colorectal Cancer Patients Followed Up with a Low-Intensity Regime.","authors":"Prasanth Poolakkil, Nizamuddeen Pareekkutty, Satheesan Balasubramanian, Bindu Anilkumar","doi":"10.1007/s13193-025-02227-6","DOIUrl":"https://doi.org/10.1007/s13193-025-02227-6","url":null,"abstract":"<p><p>Treatment for colorectal cancer has improved significantly over the last few decades. The feasibility of treating colorectal cancer recurrence is also increasing. The surveillance protocol applied influences the pattern of diagnosis of recurrence. Adherence to intense follow up protocols may be challenged by limitation of resource, pointing to the scope of forming tailored strategies. The objectives were to determine the rate of salvage, disease-free and overall survival, the types of local therapy applied, morbidity associated with radical local treatment, and the factors influencing survival of patients followed up using a low intensity regimen after curative treatment for recurrent colorectal cancer. We included patients diagnosed with colorectal cancer recurrence from January 2010 to December 2016 at the institute. The clinicopathological and treatment details were collected. Treatment outcomes were analyzed and compared with the baseline characteristics. Of 109 recurrences, 26 (23.8%) were offered curative therapy. Locoregional treatment modalities consisted of four cases of pelvic exenteration (18.2%), four (18.2%) resections of peritoneal deposits including two (9.1%) multivisceral resections, four (18.2%) hepatic resections, two (9.1%) lung metastasectomies, one (4.5%) retroperitoneal lymph node dissection, and two (4.5%) ablative procedures. Four (18.2%) and one (4.5%) cases received chemoradiotherapy and systemic therapy alone. Surgical resection had 6.2% Clavien-Dindo grade III, 25% grade II, and 25% grade I morbidities. With a median follow-up of 95 months, the median DFS and OS were 48 months and 55 months for curatively treated patients. The rate of curative therapy was low in a low-intensity follow-up regimen (23.8%). Yet, curative treatment including complex resections offers a survival advantage with acceptable morbidity rates, in select patients with limited disease affecting a single region.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1376-1383"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GLI1-VENTX Expression Pattern as a Prognostic Value for Non-Metastatic Early Esophageal Squamous Cell Carcinoma. GLI1-VENTX表达模式在非转移性早期食管鳞状细胞癌中的预后价值
IF 0.7 Q4 ONCOLOGY Pub Date : 2025-12-01 Epub Date: 2025-02-24 DOI: 10.1007/s13193-025-02246-3
Elaheh Gheybi, Fatemeh Molaei, Mohammad Mahdi Forghanifard

Cell signaling pathways are important in different biological processes such as cell survival, proliferation, differentiation, as well as tumorigenesis. The complex interactions between genes and signaling pathways have a role in the progression and development of malignancies. Our aim in this study was to explore the concomitant expression of GLI1 and VENTX genes in esophageal squamous cell carcinoma (ESCC) and evaluate its relevance with clinicopathological features. Levels of GLI1 and VENTX mRNA expression in 50 ESCC patients were compared to the correlated margin normal tissues using relative comparative RT-qPCR. A significant correlation between the mRNA expression of GLI1 and VENTX was observed in ESCC patients (P = 0.003, P < 0.05 ). Expression of GLI1 was significantly increased in samples with high levels of VENTX mRNA expression. Moreover, a significant correlation between VENTX and GLI1 was detected in non-metastatic early tumors (stages I and II). The significant correlation between these genes in non-metastasized early tumors indicates the importance of GLI1 and VENTX concomitant expression as a value for early ESCCs. It may be extrapolated that VENTX through the BMP pathway activates the expression of GLI1 followed by aggressive phenotype in ESCC.

细胞信号通路在细胞存活、增殖、分化以及肿瘤发生等不同的生物学过程中起着重要的作用。基因和信号通路之间复杂的相互作用在恶性肿瘤的进展和发展中起着重要作用。本研究的目的是探讨GLI1和VENTX基因在食管鳞状细胞癌(ESCC)中的共同表达,并评估其与临床病理特征的相关性。采用相对比较RT-qPCR将50例ESCC患者的GLI1和VENTX mRNA表达水平与相关边缘正常组织进行比较。在ESCC患者中GLI1和VENTX mRNA的表达有显著相关性(P = 0.003, P 0.05)。在VENTX mRNA高表达的样品中,GLI1的表达显著增加。此外,在非转移性早期肿瘤(I期和II期)中检测到VENTX和GLI1之间的显著相关性。这些基因在非转移性早期肿瘤中的显著相关性表明GLI1和VENTX同时表达对于早期escc具有重要价值。可以推断,通过BMP通路的VENTX激活了ESCC中GLI1的表达,随后出现了侵袭性表型。
{"title":"GLI1-VENTX Expression Pattern as a Prognostic Value for Non-Metastatic Early Esophageal Squamous Cell Carcinoma.","authors":"Elaheh Gheybi, Fatemeh Molaei, Mohammad Mahdi Forghanifard","doi":"10.1007/s13193-025-02246-3","DOIUrl":"https://doi.org/10.1007/s13193-025-02246-3","url":null,"abstract":"<p><p>Cell signaling pathways are important in different biological processes such as cell survival, proliferation, differentiation, as well as tumorigenesis. The complex interactions between genes and signaling pathways have a role in the progression and development of malignancies. Our aim in this study was to explore the concomitant expression of GLI1 and VENTX genes in esophageal squamous cell carcinoma (ESCC) and evaluate its relevance with clinicopathological features. Levels of GLI1 and VENTX mRNA expression in 50 ESCC patients were compared to the correlated margin normal tissues using relative comparative RT-qPCR. A significant correlation between the mRNA expression of GLI1 and VENTX was observed in ESCC patients (<i>P</i> = 0.003, <i>P</i> <math><mrow><mo><</mo> <mn>0.05</mn></mrow> </math> ). Expression of GLI1 was significantly increased in samples with high levels of VENTX mRNA expression. Moreover, a significant correlation between VENTX and GLI1 was detected in non-metastatic early tumors (stages I and II). The significant correlation between these genes in non-metastasized early tumors indicates the importance of GLI1 and VENTX concomitant expression as a value for early ESCCs. It may be extrapolated that VENTX through the BMP pathway activates the expression of GLI1 followed by aggressive phenotype in ESCC.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1482-1487"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Surgical Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1